HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

B C Chakraborty Selected Research

Immuvac

1/2017A randomized trial of TLR-2 agonist CADI-05 targeting desmocollin-3 for advanced non-small-cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


B C Chakraborty Research Topics

Disease

1Disease Progression
01/2017
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2017
1Chronic Hepatitis B
08/2016
1Fibrosis (Cirrhosis)
08/2016
1Infections
08/2016
1Respiratory Insufficiency (Respiratory Failure)
08/2010

Drug/Important Bio-Agent (IBA)

1PlatinumIBA
01/2017
1ImmuvacIBA
01/2017
1taxaneIBA
01/2017
1Hepatitis B e AntigensIBA
08/2016
1SmokeIBA
08/2010

Therapy/Procedure

1Therapeutics
01/2017
1Drug Therapy (Chemotherapy)
01/2017